SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-000849
Filing Date
2020-03-17
Accepted
2020-03-17 15:36:51
Documents
5
Period of Report
2020-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannapharmrx_8k.htm 8-K 20482
2 AMENDING AGREEMENT NO. 3 TO SHARE PURCHASE AGREEMENT cannapharmrx_8k-ex1006.htm EX-10.6 55368
3 PRESS RELEASE cannapharmrx_8k-ex9901.htm EX-99.1 11923
4 GRAPHIC sunniva.jpg GRAPHIC 4287
5 GRAPHIC cannapharmrx.jpg GRAPHIC 4962
  Complete submission text file 0001683168-20-000849.txt   102246
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 20720819
SIC: 2834 Pharmaceutical Preparations